These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15702203)

  • 21. [Meta-analyses or megatrials: same level of proof?].
    Mismetti P; Cucherat M; Laporte S
    Presse Med; 2007 Mar; 36(3 Pt 2):524-30. PubMed ID: 17275251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
    Zhang F; Miyaoka E; Huang F; Tanaka Y
    J Biopharm Stat; 2015; 25(5):921-38. PubMed ID: 24919157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Bayesian and frequentist meta-analytical approaches for analyzing time to event data.
    Bennett MM; Crowe BJ; Price KL; Stamey JD; Seaman JW
    J Biopharm Stat; 2013; 23(1):129-45. PubMed ID: 23331227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
    Curtin F; Altman DG; Elbourne D
    Stat Med; 2002 Aug; 21(15):2131-44. PubMed ID: 12210629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of method comparison studies.
    Williamson PR; Lancaster GA; Craig JV; Smyth RL
    Stat Med; 2002 Jul; 21(14):2013-25. PubMed ID: 12111884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach to noninferiority testing: documented proof rather than arbitrary margins.
    Cleophas TJ; Zwinderman AH
    Am J Ther; 2012 Mar; 19(2):101-7. PubMed ID: 20975529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients.
    Blumberg N; Zhao H; Wang H; Messing S; Heal JM; Lyman GH
    Transfusion; 2007 Apr; 47(4):573-81. PubMed ID: 17381614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic reviews and meta-analyses of randomized trials: principles and pitfalls.
    da Costa BR; Juni P
    Eur Heart J; 2014 Dec; 35(47):3336-45. PubMed ID: 25416325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
    Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
    Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A likelihood approach to meta-analysis with random effects.
    Hardy RJ; Thompson SG
    Stat Med; 1996 Mar; 15(6):619-29. PubMed ID: 8731004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
    Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S
    Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based practice: how to perform and use systematic reviews for clinical decision-making.
    Kranke P
    Eur J Anaesthesiol; 2010 Sep; 27(9):763-72. PubMed ID: 20523217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2145-59. PubMed ID: 12210630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes.
    Trikalinos TA; Hoaglin DC; Schmid CH
    Stat Med; 2014 Apr; 33(9):1441-59. PubMed ID: 24285290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian bivariate meta-analysis of sensitivity and specificity: summary of quantitative findings in 50 meta-analyses.
    Menke J
    J Eval Clin Pract; 2014 Dec; 20(6):844-52. PubMed ID: 24828853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of reporting of noninferiority and equivalence randomized trials.
    Le Henanff A; Giraudeau B; Baron G; Ravaud P
    JAMA; 2006 Mar; 295(10):1147-51. PubMed ID: 16522835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternatives for discounting in the analysis of noninferiority trials.
    Snapinn SM
    J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of clinical trials: a consumer's guide.
    Geller NL; Proschan M
    J Biopharm Stat; 1996 Nov; 6(4):377-94. PubMed ID: 8969975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.